Clinical

Radiopharmaceutical Dosing Under FDA’s New Spotlight: What You Should Know

Expanding Access to CART Therapies: TD2 Oncology Featured in SCRS inFocus

The Thing About Theranostics…

Why Small Molecules Are Still a Big Deal

The Rising Impact of ADCs in Cancer Treatment

A Science Driven Approach: Translating Preclinical ADC Insights into Clinical Success

The Cost of Delay: Quantifying the Financial Impact of Inefficient Clinical Trial Start-Up

Leveraging Flow Cytometry to Drive Better Patient Outcomes in Hematologic Malignancy Clinical Trials

Challenges in Radiopharmaceutical Development for Oncology Therapies

Emerging Trends in Radiopharmaceuticals

Optimizing Site Selection for Faster Patient Enrollment in Oncology Trials

Navigating the Complexities of Clinical Trial Start-Up

Climbing the Mountain: Current Challenges in Early Phase Oncology Clinical Trials

Rule-Based Approach in Early-Phase Oncology

Early Phase Oncology Trial Designs: Model-Based Approach

Early Phase Oncology Trial Designs: The Model-Assisted Approach

Efficient Data Management: One Way to Expedite the Clinical Development Process